TherapeuticsMD
TXMD
#10160
Rank
ยฃ15.11 M
Marketcap
ยฃ1.31
Share price
8.07%
Change (1 day)
32.26%
Change (1 year)

Revenue for TherapeuticsMD (TXMD)

Revenue in 2025 (TTM): ยฃ1.93 Million

According to TherapeuticsMD's latest financial reports the company's current revenue (TTM ) is ยฃ1.92 Million. In 2024 the company made a revenue of ยฃ1.4 Million an increase over the revenue in the year 2023 that were of ยฃ1.02 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TherapeuticsMD from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ1.93 M38.1%
2024 ยฃ1.4 M37.31%
2023 ยฃ1.02 M-51.5%
2022 ยฃ2.1 M-96.73%
2021 ยฃ64.41 M35.35%
2020 ยฃ47.59 M25.7%
2019 ยฃ37.86 M198.51%
2018 ยฃ12.68 M2.17%
2017 ยฃ12.41 M-20.86%
2016 ยฃ15.68 M15.41%
2015 ยฃ13.59 M40.83%
2014 ยฃ9.65 M81.41%
2013 ยฃ5.32 M125.22%
2012 ยฃ2.36 M1.43%
2011 ยฃ2.32 M17555.38%
2010 ยฃ0.01 M101.96%
2009 ยฃ0 M
2006 ยฃ0.51 M-4.74%
2005 ยฃ0.53 M65.81%
2004 ยฃ0.32 M32.82%
2003 ยฃ0.24 M36.86%
2002 ยฃ0.17 M-22.07%
2001 ยฃ0.22 M-6.98%
2000 ยฃ0.24 M86.25%
1999 ยฃ0.13 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Agile Therapeutics
AGRX
ยฃ16.19 M 742.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
ยฃ0.23 B 12,040.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ47.13 B 2,453,436.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ44.77 B 2,330,654.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
ยฃ1.76 B 91,726.65%๐Ÿ‡ฌ๐Ÿ‡ง UK